Literature DB >> 12622497

Opioid-induced respiratory depression is associated with increased tidal volume variability.

T Bouillon1, J Bruhn, H Roepcke, A Hoeft.   

Abstract

BACKGROUND AND
OBJECTIVE: mu-agonistic opioids cause concentration-dependent hypoventilation and increased irregularity of breathing. The aim was to quantify opioid-induced irregularity of breathing and to investigate its time-course during and after an opioid infusion, and its ability to predict the severity of respiratory depression.
METHODS: Twenty-three patients breathing spontaneously via a continuous positive airway pressure (CPAP) mask received an intravenous (i.v.) infusion of alfentanil (2.3 microg kg(-1) min(-1), 14 patients) or pirinitramide (piritramide) (17.9 microg kg(-1) min(-1), nine patients) until either a cumulative dose of 70 microg kg(-1) for alfentanil or 500 microg kg(-1) for pirinitramide had been achieved or the infusion had to be stopped for safety reasons. Tidal volumes (VT) and minute ventilation were measured with an anaesthesia workstation. For every 20 breaths, the quartile coefficient was calculated (Qeff20V(T)).
RESULTS: Both the decrease of minute volume and the increase of Qeff20V(T) during and after opioid infusion were highly significant (P < 0.001, ANOVA). Patients in which the alfentanil infusion had to be terminated prematurely had lower minute volumes (P = 0.002, t-test) and higher Qeff20V(T) (P = 0.034, t-test) than those who received the complete dose. Changes in the regularity of breathing measured as Qeff20V(T) parallel those of minute ventilation during and after opioid infusion.
CONCLUSIONS: Opioids cause a more complicated disturbance of the control of respiration than a mere resetting to higher PCO2. Furthermore, Qeff20V(T) appears to predict the severity of opioid-induced respiratory depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622497     DOI: 10.1017/s0265021503000243

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  25 in total

Review 1.  [Piritramide : A critical review].

Authors:  M Hinrichs; A Weyland; C Bantel
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

2.  Kölliker-Fuse nuclei regulate respiratory rhythm variability via a gain-control mechanism.

Authors:  Rishi R Dhingra; Mathias Dutschmann; Roberto F Galán; Thomas E Dick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-14       Impact factor: 3.619

3.  Automated analysis of breathing waveforms using BreathMetrics: a respiratory signal processing toolbox.

Authors:  Torben Noto; Guangyu Zhou; Stephan Schuele; Jessica Templer; Christina Zelano
Journal:  Chem Senses       Date:  2018-09-22       Impact factor: 3.160

4.  Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

Authors:  Corey S Davis; Derek Carr; Jessica K Southwell; Leo Beletsky
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

5.  Increased tidal volume variability in children is a better marker of opioid-induced respiratory depression than decreased respiratory rate.

Authors:  Sean J Barbour; Christine A Vandebeek; J Mark Ansermino
Journal:  J Clin Monit Comput       Date:  2004-06       Impact factor: 2.502

Review 6.  Are opioids associated with sleep apnea? A review of the evidence.

Authors:  James M Walker; Robert J Farney
Journal:  Curr Pain Headache Rep       Date:  2009-04

7.  Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing.

Authors:  James M Walker; Robert J Farney; Steven M Rhondeau; Kathleen M Boyle; Karen Valentine; Tom V Cloward; Kevin C Shilling
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

8.  Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone.

Authors:  Jason Boland; Elaine Boland; David Brooks
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

9.  Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice.

Authors:  Adrienn G Varga; Brandon T Reid; Brigitte L Kieffer; Erica S Levitt
Journal:  J Physiol       Date:  2019-11-02       Impact factor: 5.182

10.  Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study.

Authors:  Katri Elina Clemens; Ines Quednau; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2008-08-22       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.